✦ LIBER ✦

Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial

✍ Scribed by A. SHIRAHATA; K. FUKUTAKE; J. MIMAYA; J. TAKAMATSU; M. SHIMA; H. HANABUSA; H. TAKEDANI; Y. TAKASHIMA; T. MATSUSHITA; A. TAWA; S. HIGASA; N. TAKATA; M. SAKAI; K. KAWAKAMI; Y. OHASHI; H. SAITO

Book ID: 108775773
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 647 KB
Volume: 18
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2011.02548.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of clot waveform analysis and th

Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report

✍ A. Shirahata; K. Fukutake; J. Mimaya; J. Takamatsu; M. Shima; H. Hanabusa; H. Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB

Safety, pharmacokinetics and efficacy of

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross-over, phase I/II study

✍ J. SPIRA; O. PLYUSHCH; N. ZOZULYA; R. YATUV; I. DAYAN; A. BLEICHER; M. ROBINSON; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Occurrence of inhibitors in previously u

Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate

✍ A. GRINGERI; M. MONZINI; G. TAGARIELLO; F. A. SCARAGGI; P. M. MANNUCCI; THE EMOC 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

A Phase I/II Clinical Trial to Evaluate

A Phase I/II Clinical Trial to Evaluate a Combination of Recombinant Human Platelet-Derived Growth Factor-BB and Recombinant Human Insulin-Like Growth Factor-I in Patients with Periodontal Disease

✍ Howell, T. Howard; Fiorellini, Joseph P.; Paquette, David W.; Offenbacher, Steve 📂 Article 📅 1997 🏛 American Academy of Periodontology 🌐 English ⚖ 625 KB

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

A phase I and pharmacokinetic study of d

A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: A study of the National Cancer Institute of Canada Clinical Trials Group

✍ Glenwood Goss; Frances A. Shepherd; Scott Laurie; Isabelle Gauthier; N. Leighl; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 137 KB